ADCC Against Gastric Cancer Cells

Evaluation of Antibody-dependent Cell Cytotoxicity (ADCC) Against Gastric Cancer Cells

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02078362

Enrollment

Registered

2014-03-05

Start date

2013-09-30

Completion date

2018-05-31

Last updated

2015-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

Peripheral blood will be taken from the enrolled patients at National University Hospital and from healthy volunteers. ADCC assay will be performed for evaluating efficacy of new medicine candidates.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

21 Years to 80 Years

Healthy volunteers

Inclusion criteria

For the gastric cancer patients, patients with 21 years of age and above and younger than 80 years old who have gastric cancer can enroll in this study. For the healthy donors, healthy volunteers with 21 years of age and above and younger than 80 years old can enroll in this study.

Exclusion criteria

(A) Age of \<21 and \>80 years old (B) Pregnancy (C) Decision of unsuitableness by Principal Investigator or physician-in-charge

Design outcomes

Primary

Measure	Time frame
Percentage of cell lysis	within 1 year

Countries

Singapore

Contacts

Primary ContactWei Peng Yong, MRCP

wei_peng_yong@nuhs.edu.sg+65 6779 5555

Outcome results